Oct 21 2024

Adalimumab slashes Behçet’s uveitis relapse rate significantly more than cyclosporine

Adalimumab combined with corticosteroids led to a significantly lower rate of relapse in Behçet’s disease uveitis vs. cyclosporine alongside corticosteroids, according to data published in The Lancet Rheumatology.
“Although several immunomodulatory drugs, including cyclosporine, interferon alfa-2a and adalimumab are used in combination with corticosteroids for Behçet’s disease uveitis in clinical practice, there is no scientific consensus on which agent is preferred,” Zhenyu Zhong, MD, of the First Affiliated Hospital of Chongqing Medical University, in China, and

Read More

From Healio.com RHEUMATOLOGY • • 0

Oct 21 2024

Egypt achieves historic malaria-free certification

The World Health Organization (WHO) has certified Egypt as malaria-free, marking a significant public health milestone for a country with more than 100 million inhabitants.

Read More

From Medical News • • 0

Oct 21 2024

Egypt achieves historic malaria-free certification

The World Health Organization (WHO) has certified Egypt as malaria-free, marking a significant public health milestone for a country with more than 100 million inhabitants.

Read More

From The Medical News • • 0

Oct 21 2024

Medicare drug plans are getting better next year. some will also cost more.

When Pam McClure learned she'd save nearly $4,000 on her prescription drugs next year, she said, "it sounded too good to be true." She and her husband are both retired and live on a "very strict" budget in central North Dakota.

Read More

From The Medical News • • 0

Oct 21 2024

Medicare drug plans are getting better next year. some will also cost more.

When Pam McClure learned she'd save nearly $4,000 on her prescription drugs next year, she said, "it sounded too good to be true." She and her husband are both retired and live on a "very strict" budget in central North Dakota.

Read More

From Medical News • • 0